MATTHEW D LINNIK Insider Trading
Get free email notifications about insider trading for MATTHEW D LINNIK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW D LINNIK. MATTHEW D LINNIK is a CSO & Exec VP of Research in LA JOLLA PHARMACEUTICAL CO ($LJPC).
Address: 6455 NANCY RIDGE DRIVE SAN DIEGO 92121 CA
Companies in which MATTHEW D LINNIK is an Insider
LA JOLLA PHARMACEUTICAL CO
Trading Symbol: LJPCIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MATTHEW D LINNIK: CSO & Exec VP of Research
Holdings: 1,300 shares
Current Value: $25,311
Latest Transaction: Dec 27 2006
$LJPC Market Capitalization: $355.22M
$LJPC Previous Close: $19.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MATTHEW D LINNIK
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 27 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | S | 3.03 | 365 | 1,106 | 1,300 | 1.7 K to 1.3 K (-21.92 %) |
Dec 27 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | S | 2.88 | 5,000 | 14,394 | 1,665 | 6.7 K to 1.7 K (-75.02 %) |
Dec 20 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.00 | 2,500 | 7,500 | 6,665 | 9.2 K to 6.7 K (-27.28 %) |
Dec 20 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.01 | 3,500 | 10,530 | 9,165 | 12.7 K to 9.2 K (-27.64 %) |
Dec 18 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.02 | 7,500 | 22,625 | 12,665 | 20.2 K to 12.7 K (-37.19 %) |
Dec 18 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.12 | 1,500 | 4,680 | 20,165 | 21.7 K to 20.2 K (-6.92 %) |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Option Exercise | A | 4.46 | 310,430 | 1,384,518 | 361,027 |